288
Participants
Start Date
June 27, 2018
Primary Completion Date
September 30, 2024
Study Completion Date
December 18, 2024
Hypertonic saline
Nebulized hypertonic saline solution (6%)
Carbocysteine 750 MG
Carbocisteine tablet
Stoke Mandeville Hospital, Aylesbury
Belfast City Hospital, Belfast Health and Social Care Trust, Belfast
Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham
Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, Brompton
Ninewells Hospital and Medical School, NHS Tayside, Dundee
Royal Infirmary Edinburgh, NHS Lothian, Edinburgh
Royal Free Hospital, Royal Free London NHS Foundation Trust, Hamstead
Princess Alexandra Hospital, The Princess Alexandra Hospital NHS Trust, Harlow
Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster
Altnagelvin Area Hospital, Western Health and Social Care Trust, Londonderry
Freeman Hospital, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford
Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton
Royal Gwent Hospital, Aneurin Bevan University Health Board, Wales
Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool
Bradford Teaching Hospitals, Bradford
Cardiff & Vale University Heath Board, Llandough
Milton Keynes University Hospital, Milton Keynes
Northumbria NHS Foundation Trust, North Shields
Sandwell & West Birmingham, West Bromwich
Queen's University, Belfast
OTHER
Belfast Health and Social Care Trust
OTHER